WATER INDUSTRY FEATURES, INSIGHTS, AND ANALYSIS
-
The Enzyme Bottleneck: Why Conventional Lake Management Is Failing — And What The Science Says About Genuine Bio-Dredging
For decades, the dominant framework for assessing and managing lake health has been built around surface water measurements: chlorophyll-a, total phosphorus, water clarity, and the composite Trophic State Index derived from them. These metrics are familiar, standardised, and widely accepted. They are also, according to a growing body of peer-reviewed literature, measuring the wrong part of the lake.
-
Ozone Off-Gas: What It Reveals About System Efficiency, Safety, and Design
Learn how ozone off-gas impacts system efficiency, safety, and performance, and why monitoring and management are critical for optimized water treatment operations.
-
UK Reservoirs, Water Shortages, And Legionella Risks
Is there a clear link between a less plentiful water supply and an increase in Legionella in our domestic water systems?
-
The Devastating Legacy Of Algaecides: Why The Quick Fix Is Failing Our Lakes As warmer months approach, water management professionals must confront the compounding consequences of biocidal algae treatments.
-
What Is The Future Of Source Water Protection? Water utility managers and municipal leaders have long struggled amid the convergence of several threats to public water supplies. During a recent Water Online Live event, I sat with a panel of industry experts to examine the transition from reactive crisis management to a proactive, adaptive resilience framework.
-
Drinking Water Contaminated With 'Forever Chemicals' During Pregnancy Linked To An Increased Risk Of Childhood Asthma
While most of us are routinely exposed to low levels of PFAS, some communities are exposed to far higher levels from nearby pollution sources. A new study shows that in one of these at-risk communities, children were more likely to develop asthma if their mothers were exposed to very high PFAS levels during pregnancy.
-
The Pragmatic Shift In Source Water Protection: Moving From Symptom Management To Root-Cause Accountability A shift in how we approach source water protection is long overdue. Currently, we are trapped in a cycle of escalating costs, forced to treat symptoms like algae and invasive weeds expediently with chemicals while the underlying risk in the reservoir compounds. True risk management requires breaking this cycle.
-
The AWWA Said $2.4 Trillion. It Missed The Compound Interest. Einstein once said of compound interest, "He who understands it, earns it. He who doesn't, pays it." The same logic of compounding applies to the organic sediment accumulating on the floor of your drinking water reservoir. The longer you wait to address it, the more exponentially expensive it becomes to fix.
-
Designing Resilient PFAS Treatment Strategies For Water Agencies Water agencies across the U.S. are facing a rapidly evolving regulatory landscape for per- and polyfluoroalkyl substances (PFAS) that poses a conundrum: Should they take a cautious or aggressive approach to treating PFAS contamination in their water system?
-
The Future Of In Situ Chemical Oxidation For Targeted Solvent Destruction
The U.S. EPA’s 2026 trichloroethylene (TCE) compliance deadlines are now forcing a concrete shift toward source-zone destruction. In situ chemical oxidation (ISCO), sequenced with enhanced bioremediation, is proving to be the most credible path to groundwater contaminant rebound mitigation.
VIEWS ON THE LATEST REGS
-
Despite renewed public concern over fluoride and cognition, the National Toxicology Program’s findings focus on high‑fluoride groundwater conditions — not the controlled levels used in U.S. drinking water systems. Understanding that distinction is critical for utilities navigating policy questions and community expectations.
-
In this Q&A, Dr. Elke Süss of Metrohm addresses the urgent need for haloacetic acid testing in response to “one of the most significant updates to EU drinking water monitoring in recent years.”
-
With the U.S. EPA's PFAS rules now in place, utilities are finding themselves with a growing number of questions regarding how to treat these chemicals, the potential costs, and much more. For answers, Water Online's chief editor, Kevin Westerling, hosted an Ask Me Anything session featuring Ken Sansone, Senior Partner at SL Environmental Law Group; Kyle Thompson, National PFAS Lead at Carollo Engineers; and Lauren Weinrich, Principal Scientist at American Water.
-
A Q&A to explain and resolve issues confronting water suppliers as they endeavor to comply with the monitoring requirements of federal PFAS regulations.
-
Assessing what lies ahead in the 10-year race to go lead-free, otherwise known as the Lead and Copper Rule Improvements (LCRI).
MORE WATER INDUSTRY FEATURES
-
Read more about how Fujifilm Diosynth Biotechnologies evaluated a prime filter with challenging simulant solutions and how the experimental data confirmed superior performance, which demonstrated twice the throughput.
-
Ozone and UV-AOP each offer powerful contaminant removal for drinking water, wastewater, and reuse applications. Their unique strengths—and potential synergy—help utilities meet diverse treatment goals efficiently.
-
Multi-well inserts allowing for a two-chamber system that can expose cell cultures from above and below provide greater versatility and expand research options compared to standard cell culture plates.
-
The World Medical Association (WMA) has announced a significant, rare update to its cornerstone ethical document, the Declaration of Helsinki, which guides medical research involving human participants.
-
In this article, Transcend will break down the evolution and impact of PFAS regulations over the years while suggesting innovative technology to assist the affected industries.
-
Explore a UPLC-UV method using Empower 3 Software to assess synthetic peptide purity. Learn how integrated tools streamline impurity tracking, data reporting, and compliance in peptide analysis workflows.
-
NMR reveals far more than structure, offering insights into purity and molecular behavior. Advanced analysis unlocks deeper value from data to better understand mixtures and 3D structures.
-
Whether it’s a hurricane, flood, fire, or extended power outage, the systems that sustain communities are often the first to be tested. And among all treatment technologies available, membrane bioreactors (MBRs) have proven uniquely resilient.
-
Long-standing myths about GAC reactivation are being increasingly challenged, revealing performance, cost, and sustainability benefits many utilities may have overlooked.
-
Like a referee in a contest, advanced analytical methods are essential to mediate the push and pull of different factors influencing therapeutic efficacy.
-
Focusing on lifecycle ROI reveals ozone's value. It significantly reduces chemical and operational costs while extending filter media life, providing measurable long-term financial savings and compliance resilience.
-
Explore the technical hurdles of APOE-targeted development and the precision tools—including target proteins and pre-formed fibrils (PFFs)—required to bridge the gap from risk identification to commercial success.
-
Hear from patients and caregivers across various therapeutic areas as they offer tips on improving the clinical trial experience.
-
Explore how Fc engineering transforms antibodies into precise therapeutic tools by modulating immune effector functions and extending half-life to improve patient outcomes and overcome complex clinical challenges.
-
Oxygen heterogeneity, caused by pressure variations and other factors in large-scale bioreactors, can significantly impact cell growth and product yield.
-
Gain sponsor approval by positioning technology as key to streamlined workflows, compliance, and patient safety — reducing risk and improving collaboration. Explore strategies now.
-
The Toledo water crisis exposed treatment gaps, highlighting harmful algal blooms as a core design challenge requiring flexible, multi-barrier systems and scenario-based planning.
-
Explore how embedding inclusion early in clinical development enhances enrollment, strengthens data integrity, and improves outcomes, especially in oncology and rare disease trials.